Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>Events

  Events

November 2013
Scientific News
Liquid Biopsies: Utilization of Circulating Biomarkers for Minimally Invasive Diagnostics Development
Market Trends in Biofluid-based Liquid Biopsies: Deploying Circulating Biomarkers in the Clinic. Enal Razvi, Ph.D., Managing Director, Select Biosciences, Inc.
Study Questions Presence in Blood of Heart-Healthy Molecules from Fish Oil Supplements
A new study from the Perelman School of Medicine at the University of Pennsylvania questions the relevance of fish oil-derived SPMs and their purported anti-inflammatory effects in humans.
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
Young South African Women can Adhere to Daily PrEP Regimen as HIV Prevention
NIH-funded study finds men in Bangkok, Harlem also successful in taking daily dose.
Key Player in Diabetic Kidney Disease Revealed
Discovery could lead to new and better diagnostic marker for chronic kidney disease.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Santhera Announces First Patient Dosing with Omigapil in CMD
Company announces full patient recruitment of CALLISTO study.
Study Shows Promise of Precision Medicine for Most Common Type of Lymphoma
The study appeared online July 20, 2015, in Nature Medicine.
HIV Control Through Treatment Durably Prevents Heterosexual Transmission of Virus
NIH-funded trial proves suppressive antiretroviral therapy for HIV-infected people effective in protecting uninfected partners.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.
08 Oct 2013 - 14 Nov 2013
Live-on-the-Web
LC/MS Fundamentals and Applications
05 Nov 2013 - 06 Nov 2013
Philadelphia, PA, USA
9th Pharmaceutical Meeting Planners' Summit
Clinical Trial Billing Bootcamp - Nashville
11 Nov 2013 - 12 Nov 2013
Nashville, TN, USA
Clinical Trial Billing Bootcamp - Nashville
World Biosimilar Congress 2013
12 Nov 2013 - 13 Nov 2013
Geneva, Switzerland
World Biosimilar Congress 2013
World Drug Repositioning Congress 2013
14 Nov 2013 - 15 Nov 2013
Geneva, Switzerland
World Drug Repositioning Congress 2013
Medical Device Group Purchasing and Strategic Accounts Conference
14 Nov 2013 - 15 Nov 2013
Dallas, TX, USA
Medical Device Group Purchasing and Strategic Accounts Conference
The EUROPEAN STATISTICAL FORUM - Missing Data in Clinical Trials
18 Nov 2013 - 18 Nov 2013
Amsterdam, Netherlands
The EUROPEAN STATISTICAL FORUM - Missing Data in Clinical Trials
Clinical Trials in CNS
18 Nov 2013 - 19 Nov 2013
London, UK
Clinical Trials in CNS
CLINICAL TRIALS SUPPLY CHAIN 2013 
20 Nov 2013 - 21 Nov 2013
Berlin, Germany
CLINICAL TRIALS SUPPLY CHAIN 2013 
<< 1 2 >>
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!